phosphorylethanolamine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franks, SE | 1 |
| Smith, MR | 1 |
| Arias-Mendoza, F | 1 |
| Shaller, C | 1 |
| Padavic-Shaller, K | 1 |
| Kappler, F | 1 |
| Zhang, Y | 1 |
| Negendank, WG | 1 |
| Brown, TR | 1 |
1 other study available for phosphorylethanolamine and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Phosphomonoester concentrations differ between chronic lymphocytic leukemia cells and normal human lymphocytes.
Topics: Adult; Aged; Case-Control Studies; Ethanolamines; Female; Glycerylphosphorylcholine; Humans; Leukemi | 2002 |